Twist Bioscience Corp
F:0ME
Twist Bioscience Corp
F:0ME
Price:
59.58
EUR
0.3%
Market Cap:
€3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Twist Bioscience Corp
F:0ME
|
US |
|
S
|
St Joe Co
XMUN:JOE
|
US |
|
Kalbe Farma Tbk PT
IDX:KLBF
|
ID |
|
Kainos Laboratories Inc
TSE:4556
|
JP |
|
MNC Vision Networks Tbk PT
IDX:IPTV
|
ID |
|
Getty Realty Corp
F:GRL
|
US |
|
TPG RE Finance Trust Inc
NYSE:TRTX
|
US |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
0ME Price Targets Summary
Twist Bioscience Corp
Twist Bioscience Corp
Wall Street analysts forecast 0ME stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0ME is 26.37 EUR with a low forecast of 22.89 EUR and a high forecast of 31.73 EUR.
Lowest Forecast
Price Target
22.89
EUR
62% Downside
Average Forecast
Price Target
26.37
EUR
56% Downside
Highest Forecast
Price Target
31.73
EUR
47% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ME's stock price target?
Price Target
26.37
EUR
26.37
EUR
According to Wall Street analysts, the average 1-year price target for 0ME is 26.37 EUR with a low forecast of 22.89 EUR and a high forecast of 31.73 EUR.
What is the Revenue forecast for Twist Bioscience Corp?
Projected CAGR
16%
16%
Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 5 years is 16%.
